Protective role of Zingiber officinale Roscoe on aceclofenac induced oxidative stress in rat liver

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 495-501

  Darbar, Soumen ^a   Bose, A ^a   Chattaraj, T K ^a   Pal, T K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Aceclofenac; Oxidative stress; Zingiber officinale

Indexed keywords

ACECLOFENAC; CATALASE; GINGER EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER; LIVER HOMOGENATE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 77953459974     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kowaltowski A.J. and Vercesi A.E., Mitochondrial damage induced by conditions of oxidative stress, Free Radic. Biol. Med., 1999, 26, 463-471.
2. Halliwell B., Antioxidants and human diseases: a general introduction, Nutr. Rev., 1997, 55, S44-S52.
3. Garcia-Rodriguez L.A., Williams R., Derby L.E., et al., Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors, Arch, Int, Med, 1994, 154, 311-316.
4. Manoukian A.V. and Carson J.L., Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention, Drug Safety, 1996, 15, 64-71.
5. Sgro C., Clinard F., Ouazir K. et al., Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 2002, 36, 451-455.
6. Sheen C.L., Dillon J.F., Bateman D.N., Simpson K.J. and MacDonald T.M., Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-thecounter supply of paracetamol, aspirin and ibuprofen, Pharmacoepidemiol Drug Saf., 2002, 11, 329-331.
7. Dierkes-Globisch A., Schafer R. and Mohr H.H., Asymptomatic diclofenac-induced acute hepatitis [in German], Dtsch. Med. Wochenschr., 2000, 125, 797-800.
8. Koff R.S., Liver disease induced by nonsteroidal anti-inflammatory drugs. In: Borda I.T, Koff R.S, eds. A profile of adverse effects. Philadelphia, Hanley and Belfus, 1992,133-145.
9. Zimmerman H.J., Update on hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives andcardiac and psychotropic agents, Semin. Liver Dis., 1990, 10, 322-338.
10. Rabinovitz M. and Van Thiel D.H., Hepatotoxicity of non-steroidal anti-inflammatory drugs, Am. J. Gastroenterol., 1992, 87, 1696-1704.
11. Walker A.M., Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal anti-inflammatory drugs, Arthritis Rheum., 1997, 40, 201-208.
12. Bjorkman D., Nonsteroidal anti-inflammatory drug associated toxicity of the liver, lower gastrointestinal tract and the esophagus, Am. J. Med., 1998, 105, 17-21.
13. Ward D.E., Veys E.M., Bowdler J.M. et al., Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis, Clin. Rheumatol., 1995, 14, 656-662.
14. Gonzalez E., de la Cruz C., de Nicolas R. et al., Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis, Agents Actions, 1994, 41, 171-178.
15. Yamazaki R., Kawai S., Matsuzaki T. et al., Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors, Eur. J. Pharmacol., 1997, 329, 181-187.
16. Torri G., Vignati C., Agrifoglio E. et al., Aceclofenac versus piroxicam in the management of osteoarthritis of the knee: a double-blind controlled study, Curr. Ther. Res., 1994, 55, 576-578.
17. Dooley M., Spencer C.M. and Dunn C.J., Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease, Drugs, 2001,61, 1351-1378.
18. Mascolo N., Jain R., Tain S.C. and Capasso F.J., Ethnopharmacologic investigation of ginger (Zingiber officinale), J. Ethanopharmacol., 1989, 27(1-2), 129-140.
19. Fisher-Rasmussen W., Kjaer S.K., Dahl C. and Asping U., Ginger treatment of hyperemesis gravidarm, Euro. J. Obst. Gyne. Repro. Biol., 1991, 38, 19-24.
20. Sharma JN, Srivastava KC, Gan, E.K. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 1994; 49:314-318.
21. Kamtchoving P., Mbongue G.Y., Fndio T.D. and Jatsa H.B., Evaluation of androgenic activity of Zingiber officinale and Pentadiplandra brazzeana in male rats, Asian Journal of Andology, 2002, 4(4), 299-301.
22. Ajith T.A., Hema U. and Aswathy M.S., Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status, Food and Chem. Tox., 2007, 45, 2267-2272.
23. Ohkawa H., Ohishi N. and Yagi K., Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction, Anal. Biochem., 1979, 95, 351-358.
24. Kakkar P., Das B. and Viswanathan P.N., A modified spectroscopic assay of superoxide dismutase, Indian J. Biochem. Biophys., 1984, 21,130-132.
25. Sinha K.A., Colorimetric assay of catalase, Ann. Biochem., 1972, 47, 389-394.
26. Ellman G.C., Tissue sulfhydryl groups, Arch. Biochem. Biophys., 1959, 82, 70-77.
27. Habig W.H., Pabst M.J. and Jakoby W.R., Glutathione S-transferase.The first enzymatic step in mercapturic acid formation, J. Biol. Chem., 1974, 249, 7130-7139.
28. Hafemann D.G., Sunde R.A. and Houestra W.G., Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat, J. Nutr., 1974, 104, 580-584.
29. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J., Protein measurement with folin phenol reagent, J. Bio. Chem., 1951, 193, 265-275.
30. Gram T.E. and Gillette J.R., Biotransformation of drugs. In: Bacq., Z.M (Ed.), Fundamentals of Biochemical Pharmacology. New York: Pergamen Press; 1971, p.571-609.
31. McCord J.M., Keele B.B. and Fridovich I., An enzyme based theory of obliate anaerobiosis: the physiological function of superoxide dismutase, PNAS, 1971, 68,1024-1027.
32. Pari L. and Murugan P., Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: Part II, J. Ethnopharmacol., 2003, 89, 217-219.
33. Niemela O., Parkkila S., Yla Herttuala S., Halsted C., Lanca A. and Israel Y., Covalent protein adducts in the liver as a rusult of ethanol metabolism and lipid peroxidation, Lab. Invest., 1994, 70, 537-546.
34. Vaca C.E., Wilhelm J. and Harms-Rihsdahl M., Interaction of lipid peroxidation product with DNA, A Rev. Mutat. Res. Rev. Genet. Toxicol., 1988, 195,137-149.
35. Sheela C.G. and Angusti K.T., Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn. and gugulipid in cholesterol diet fed rats, Ind. J. Exp. Biol., 1995, 33,337-341.
36. Reedy A.C., Lokes B.R., Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes, Mol. Cell. Biochem., 1992, 111,117-124.
37. Brown L.A., Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability? Alcol., 2004, 33,191-197.